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Abstract
White matter lesions (WML) are common in brain aging and are associated with dementia.
We aimed to investigate whether oxidative DNA damage and occur in WML and in
apparently normal white matter in cases with lesions. Tissue from WML and control white
matter from brains with lesions (controls lesional) and without lesions (controls non-
lesional) were obtained, using post-mortem magnetic resonance imaging-guided sampling,
from the Medical Research Council Cognitive Function and Ageing Study. Oxidative
damage was assessed by immunohistochemistry to 8-hydroxy-2′-deoxoguanosine (8-
OHdG) and Western blotting for malondialdehyde. DNA response was assessed by
phosphorylated histone H2AX (γH2AX), p53, senescence markers and by quantitative
Reverse transcription polymerase chain reaction (RT-PCR) panel for candidate DNA
damage-associated genes. 8-OHdG was expressed in glia and endothelium, with increased
expression in both WML and controls lesional compared with controls non-lesional
(P < 0.001). γH2Ax showed a similar, although attenuated difference among groups
(P = 0.03). Expression of senescence-associated β-galactosidase and p16 suggested induc-
tion of senescencemechanisms in glia. OxidativeDNAdamage and aDNAdamage response
are features ofWML pathogenesis and suggest candidate mechanisms for glial dysfunction.
Their expression in apparently normal white matter in cases with WML suggests that white
matter dysfunction is not restricted to lesions.The role of this field-effect lesion pathogenesis
and cognitive impairment are areas to be defined.
INTRODUCTION
White matter lesions (WML), which can be identified in life as
areas of increased signal on T2-weighted magnetic resonance
imaging (MRI) scans, are a common feature of the aging brain
(7, 23). They are associated with dementia, depression, impaired
motor function and Alzheimer’s disease, and may be risk factors
for progression of mild cognitive impairment to dementia and to
stroke (2, 3, 5, 8, 9, 17, 18, 30, 41, 43). The Medical Research
Council Cognitive Function and Ageing Study (CFAS) is a longi-
tudinal study of dementia and frailty in the population with a brain
donation cohort, permitting assessment of neuropathologic corre-
lates (26, 28, 45). In CFAS, WML have been found to be an
independent predictor of cognitive impairment (12).
With a role in cognitive impairment, the pathogenesis of WML,
and associated dysfunction in surrounding white matter are impor-
tant questions. The association of vascular risk factors and vascu-
lar pathology with WML suggests that they are a manifestation of
small vessel disease (25, 29, 31). Pathologically, WML consist of
areas of white matter loss, or myelin attenuation, associated with
astrogliosis, microgliosis and apoptosis of oligodendrocytes and
astrocytes (1, 21, 34, 37). While they have been considered to
represent infarction or incomplete infarction (10, 11), and there is
histopathologic evidence for a role for hypoperfusion (14), their
pathology and pathogenesis is likely to be more complex (45) and
still remains poorly defined.
Studies of the pathology and pathogenesis of WML are ham-
pered by the difficulty in recognizing these lesions in the autopsy
brain. The CFAS approach has been to use post-mortem MRI of
brain slices to guide sampling ofWML (13). This allows sampling
of lesions, and of control white matter from cases with deep
subcortical lesions (controls lesional, CL), which appears normal
on routine histologic examination, and from cases without lesions
(controls non-lesional, CNL). These studies have defined the glial
pathology of WML and shown up-regulation of microglial activity
(37, 39). Expression of hypoxia-related molecules in WML sup-
ports a role for ischemia (14), but there is also evidence of blood–
brain barrier leakage (38), suggesting that blood–brain barrier
dysfunction may play a role in their pathogenesis. Periventricular
WML appear to show some pathologic differences from WML in
deep subcortical white matter; furthermore, lesions in these two
locations may have different clinical effects (20). The current
study focuses on deep subcortical WML (hereafter referred
to simply as WML). Our previous work also demonstrated that
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apparently normal white matter from cases with lesions shows
microglial activation and altered transcriptional profile, similar to
those of the lesions (35, 37). This “field effect” suggests thatWML
(in a deep subcortical location) are associated with more wide-
spread white matter abnormality.
Hypoxia/ischemia and inflammatory mechanisms, which have
been demonstrated in this cohort, are associated with oxidative
stress, which may impair cellular function. In this study we there-
fore hypothesized that oxidative DNA damage is a feature ofWML
pathology and pathogenesis that might impair glial cell function.
We have therefore examined markers of oxidative damage and of a
DNAdamage response inWML and in the two control groups, with
(CL) and without (CNL) lesions elsewhere in the white matter.
METHODS
Cohort and tissues
Formalin-fixed paraffin-embedded (FFPE) and frozen samples of
white matter were obtained from the MRC–CFAS, with Research
Ethics Committee approval. Briefly, the study [previously
reviewed in (45)] is based around six UK centers, with recruitment
from family practitioner registries based on age at entry (>65
years). For this study, FFPE samples were obtained from the New-
castle cohort and frozen samples from the Cambridge cohort.
Using a similar case control structure to our previous white matter
studies (37–39), the cohort consisted of: (i) samples of deep
subcortical WML (DSCL); (ii) control white matter from cases
with lesions elsewhere (CL); and (iii) controls from cases without
WMLs (CNL). Tissue sampling from formalin-fixed coronal cer-
ebral slices to create FFPE blocks was guided by post-mortem
MRI scans to identify WML, as previously described (13).
Immunohistochemistry was carried out on sections from 43 FFPE
blocks derived from 40 individuals, 18 men, 22 women (WML 15
cases, mean age 86 range 74–89; CL 13 cases mean age 84.6 range
74–91; CNL 15 cases mean age 82.5 range 65–101). For frozen
tissue samples, MRI scans of the formalin-fixed contralateral brain
hemispheres were used as a guide to map WML, as they tend to
be distributed roughly symmetrically between the two brain
hemispheres. Luxol fast blue stain for myelin loss and
immunohistochemisty to the microglial marker CD68 were then
performed on the frozen samples to confirm the lesion/non-
lesional status of the sampled blocks, as lesions show myelin loss
and activated, amoeboid microglia. Twenty individuals (eight men,
12 women) provided 27 frozen blocks for analysis, comprising 11
WML (mean age 88.7 range 74–102), eight CNL (mean age 88
range 74–95) and eight CL (mean age 86.8 range 75–95).
Immunohistochemistry
FFPE blocks were sectioned at 6 μm and frozen tissue sectioned at
8 μm before fixation in ice-cold acetone at 4°C for 10 minutes.
Immunohistochemistry was performed using a standard ABC
method (Vector Laboratories, Peterborough, UK) and the signal
visualized using 3,3′-diaminobenzidine. A summary of the
primary antibodies and their conditions, including antigen
retrieval, is shown in Table 1. Negative controls consisted of sec-
tions incubated with isotype controls or with omission of the
primary antibody.
Double-staining experiments to localize 8-hydroxy-2′-
deoxoguanosine (8-OHdG) to specific cell types were performed
on FFPE sections. Staining for 8-OHdG was performed using the
same conditions as for single staining and the signal visualized
using the diaminobenzidine chromogen. Sections were then placed
in Tris-buffered saline (TBS) buffer, incubated with 1.5% relevant
normal sera for 1 h at room temperature (RT) before they were
incubated with avidin-biotin blocking kit (Vector Laboratories),
according to the manufacturer’s instructions. Sections were incu-
bated with the second primary antibody for cell type [GFAP,
CD68, oligodendrocyte-specific protein (OSP), collagen IV] at
4°C overnight. Sections were washed thoroughly with TBS buffer
and incubated with the relevant biotinylated secondary antibody
for 1 h at RT, followed by streptavidin-Tetramethylrhodamine
isothiocyanate (TRITC) (1:100 in TBS) for an hour at (RT) in
the dark. Sections were rinsed in TBS, air dried in the dark
and mounted with Vectamount containing 4’,6-diamidino-2-
phenylindole (DAPI) (Vector Laboratories). Sections were stored
in the dark at 4°C and visualized in bright field to view oxidative
damage (8-OHdG) and a fluorescent field to co-localize the
damage with specific cellular phenotypes. Image capture was per-
formed using Cell∧R (Olympus Biosystems, Watford, UK) and
Leica DMI4000B, UK. Co-localization of staining was analyzed
using Corel Paint Shop Pro X (Corel, Maidenhead, UK).
Quantification of 8-OHdG and γH2Ax
immunohistochemistry
Within each region (CNL, CL andWML), five random fields were
captured using a Nikon Eclipse 80i microscope (Nikon UK, King-
ston upon Thames). Images were transferred to a PowerPoint
program where a grid was overlaid on each image (Figure 1A). The
number of 8-OHdG positive nuclei and total number of nuclei were
assessed in the five fields for each case, allowing determination of
percentage positive nuclei. For 8-OHdG, only cells with positive
nuclei, reflecting nuclear DNA oxidative damage, were assessed;
cells with cytoplasmic only staining were not counted as positive.
Histochemistry for senescence-associated
β-galactosidase (SA-β-gal)
Prior to use, components of the SA-β-gal histochemical staining
kit (Sigma-Aldrich, Gillingham, UK) were thawed on ice and the
X-gal solution heated to 37°C for 1 h to activate. The frozen
sections were warmed to RT for 5 minutes, fixed in ready-made
fixation solution for 6 minutes at RT followed by three rinses in 1×
PBS. Freshly prepared staining mixture was then added, the sec-
tions were covered with parafilm and incubated overnight at 37°C.
Sections were rinsed in TBS, counter-stained with nuclear fast red
for 30 s followed by a rinse in deionized water before they were
dehydrated, cleared and mounted in DPX. SA-β-gal activity was
microscopically detected by the presence of a blue, insoluble pre-
cipitate within the cell. SA-β-gal was assessed semi-quantitatively
in images captured at low magnification (×20 objective). The fol-
lowing scoring criteria were used: no positive cells (0); less than
two positive cells per field (+); two to five positive cells (++); more
than six isolated positive cells (+++).
To determine if SA-β-gal activity was associated with
astrocytes, microglia and/or oligodendrocytes, GFAP-, CD68- and
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OSP-stained sections (using a standard ABC method as earlier)
were double–labeled, respectively, with SA-β-gal. To determine
the associations of SA-β-gal activity with cell cycle checkpoint
protein p16, immunolabeled frozen sections (using ABC kit) were
double-labeled with SA-β-gal.
Western blotting
Frozen white matter samples (approximately 0.5 g of tissue) from
WML, CL and CNL were homogenized and sonicated for 30 s in
buffer. Sampleswere thenmicrofuged at 14 000 rpm for 30minutes
at 4°C. The supernatant was collected and stored at −80°C until
required, while the pellet, which contained insoluble protein, was
discarded. Bradford assay (reagents from Thermo Scientific,
Loughborough, UK) was performed to determine protein concen-
tration. Prior to blotting, protein samples were diluted in an appro-
priate volume of homogenate buffer to ensure equal protein
concentrations (approximately 50 μg) for loading. Proteins were
separated by sodium dodecylsulphate-polyacrylamide gel electro-
phoresis [15% for γH2AX, 8% for MDA and 6% for DNA protein
kinase (DNA-PKcs) ] and transferred to a polyvinyl difluoride
immobilin transfer membrane (Millipore, Dundee, UK). Mem-
branes were incubated overnight with rabbit anti-γH2AX (1:1000;
Table 1. Antibodies: sources and conditions.
Antibody Species Dilution and
conditions
Antigen retrieval Supplier
Primary antibodies for immunohistochemistry
8-OHdG Mouse monoclonal 1/400
1 h RT
Pressure cooker access
revelation (×10, pH 6.5)
Abcam, Cambridge UK
ɣH2AX Rabbit monoclonal 1/1000
1 h RT
Pressure cooker EDTA pH8 R&D Systems, Abingdon UK
DNA-PK Mouse monoclonal 1/400
1 h RT
Pressure cooker EDTA pH8 Merck Biosciences Ltd,
Nottingham UK
GFAP Rabbit polyclonal 1/1000
1 h RT
Pressure cooker
TSC pH6
DakoCytomation, Ely UK
OSP Rabbit polyclonal 1/250
1 h RT
Pressure cooker
TSC pH6
Abcam, Cambridge UK
CD68 Mouse monoclonal 1/100
1 h RT
10 min in microwave TSC
pH6.3
Dako UK Ltd, Ely
Collagen IV Mouse monoclonal 1/500
O/N at 4°C
10 min in microwave TSC
pH6.3
Sigma-Aldrich, Gillingham UK
P16 Mouse monoclonal 1/100
1 h RT
Pressure cooker EDTA pH8 Bio-Genex, Fremont CA, USA
P53 Mouse monoclonal 1/50
O/N at 4°C
Pressure cooker EDTA pH8 Santa Cruz Biotechnology Inc.,
Heidelberg, Germany
P21 Mouse monoclonal 1/50
O/N at 4°C
Pressure cooker
TSC pH6
Abcam, Cambridge UK
Primary antibodies for Western blotting
ɣH2AX Rabbit monoclonal 1/1000 NA R&D systems, Abingdon UK
DNA-PK Mouse monoclonal 1/1000 NA Abcam, Cambridge UK
MDA Rabbit polyclonal 1/1000 NA Cell Biolabs, Cambridge UK
β-actin Mouse monoclonal 1/1000 NA Abcam, Cambridge UK
Secondary antibodies
Goat anti-mouse HRP Mouse polyclonal 1/5000 NA DakoCytomation, Ely UK
Goat anti-rabbit HRP Rabbit polyclonal 1/5000 NA DakoCytomation, Ely UK
8-OHdG = 8-hydroxy-2′-deoxoguanosine; γH2Ax = Phosphorylated histone H2Ax; DNA-PK = DNA protein kinase; EDTA = Ethylenediaminetetraacetic
acid; GFAP = Glial Fibrillary Acidic Protein; HRP = horseradish peroxidise; NA = not applicable; OSP = oligodendrocytes; RT = room temperature;
TSC = Tris-saline-citrate buffer.
Figure 1. Immunohistochemistry to 8-hydroxy-2′-deoxoguanosine
showing strongly labeled nuclei (red arrows), unlabelled nuclei (blue
arrows) and nuclei with faint reactivity (yellow arrow). Scale bar 50 μm.
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R&D Systems, UK), rabbit anti-MDA primary antibody (1:1000;
Cell Biolabs, Cambridge, UK) or mouse anti-DNA-PKcs (1:500;
Calbiochem, UK), followed by the appropriate horseradish peroxi-
dise (HRP)-linked secondary antibody (1:1000; DakoCytomation,
Ely, UK). To confirm equal protein loading, the membrane was
reprobed for β-actin (1:5000; AbCam, Cambridge, UK). Proteins
were detected using an enhanced chemiluminescence kit
(Amersham, UK) for chemiluminescence based-immunodetection
of HRP. Membranes were developed and scanned using the G:box
(Syngene, Cambridge, UK). Images were captured using the Intelli
Chemi setting in the GeneSnap software (Syngene). Densitometric
analysis was carried out in GeneTools (Syngene). Developed bands
were manually framed in equally sized rectangular boxes that were
manually designed to fit the largest band. Background was cor-
rected by the software automatically. Raw data of the pixel intensity
and the intensity of the bands in proportion to a defined control
were calculated and the intensity of developed bands of interest
normalized to the loading control.
Reverse transcription quantitative polymerase
chain reaction (RT-qPCR) array
RNA extraction was performed from 50 μg of frozen tissue from
each of 10 samples from the frozen cohort (three CNL, three CL,
four WML). RNA was extracted using the Direct-zol RNA
MiniPrep kit (ZymoResearch, Irvine, CA, USA). RNA quality was
checked on the Agilent 2100 Bioanalyser (Agilent, Palo Alto, CA,
USA) using an RNA 6000 Nano kit. RNA concentration was
measured on the Nanodrop Spectrophotometer (ND1000, Labtech
International, Uckfield, UK). RNA integrity number (RIN) num-
bers were 2.5, 3.1 and 4.2 for CNL cases, 2.9, 2.8 and 2.7 for CL and
2.4, 3, 3 and 1.1 for WML. 96 well RT-qPCR arrays were obtained
fromQiagen (Manchester, UK), custom designed for assessment of
gene expression related to senescence and DNA damage (see Sup-
plementary Figure S1).The selection of geneswasmade from those
available on the commercial senescence and oxidative stress-based
array based on our prior knowledge and a literature search for likely
candidates. RT-qPCR was performed according to the manufactur-
er’s instructions. Three housekeeping genes, comprising β-actin,
glyceraldehyde phosphate dehydrogenase and β-2 microglobulin,
were included in the arrays to enable normalization of the data. The
average Ct and standard deviation (SD) for the three genes was
determined for each group [average (SD) for: CNL25.71 (1.54); CL
22.49 (0.47);WML 25.45 (1.56)] and the average used for normali-
zation within each group. Further normalization to the CNL group
(to a value of 1) was used to determine fold changes for each gene
in the CL and WML groups. The plate was also designed with a
genomic DNA control, which detects non-transcribed genomic
DNA contamination with a high level of sensitivity. A reverse-
transcription control tested the efficiency of the reverse-
transcription reaction and a positive PCR control (PPC) tested the
polymerase chain reaction.
Statistic analysis
Statistic analyses for the immunohistochemical data were carried
out in Stata v12 (StataCorp LP, College Station TS, USA). Multi-
ple readings by different readers were investigated using intra-
class correlation coefficient (ICC) for consistency. Quantitative
comparisons among groups were compared using analysis of vari-
ance, taking into account non-independent structure of the data
and paired sampling of measures. Post hoc group differences were
calculated using the Tukey–Kramer pairwise, after adjustment for
multiple levels. All results were additionally checked using non-
parametric techniques and multilevel models. Associations were
assessed using Spearman’s correlation coefficient.
RESULTS
Oxidative stress
Oxidative damage to nuclear DNA was assessed by immuno-
histochemistry to 8-OHdG, with positivity ranging from faintly to
strongly positive (Figure 1). In many cells, reactivity was also
observed in the cytoplasm, presumably reflecting oxidative
damage to RNA and/or mitochondrial DNA; cytoplasmic reactiv-
ity was not assessed further in this study. Double-labeling
immunohistochemistry demonstrated reactivity in astrocytes,
oligodendrocyte, microglia and endothelial cells, although
8-OHdG-labelled astrocytes were uncommon (Figure 2).
Variability in the intensity of nuclear staining inevitably resulted
in some subjectivity in the assessment of positive cells. All cases
were therefore quantified by two observers (SM and JS; Support-
ing Information Figure S2). There was a systematic difference
between the level quantified by the two observers; however, they
were consistent in scale (ICC = 0.75, 95% confidence interval
0.53–0.87, P < 0.001). Both measures were therefore used and
adjusted for in the analysis, although the results are similar with
the mean value. There was a significant difference in the percent-
age of 8-OHdG-positive nuclei amogn the three groups (Table 2,
Figure 3A, P < 0.001), with differences seen between CNL and
CL and between CL and WML (both P < 0.05), but not seen
between CL and WML (P > 0.20).
Western blotting for malondialdehyde (MDA) revealed a band at
the expected size of 64 kDa (Figure 3D). There was no statistic
difference seen in the MDA levels among any of the groups
(P = 0.65 (Table 2, Figure 3B).
DNA damage response
TheDNAdamage responsemarker γH2Ax and the catalytic subunit
of DNA-PKcs showed widespread nuclear expression in white
Table 2. Quantification of markers.
Marker CNL CL WML
8-OHdG %
positive nuclei
Mean (SD) 24.7 (14.8) 41.8 (17.6) 38.5 (12.4)
Median (IQR) 19.4 (12.1) 41.1 (24.3) 37.8 (22.1)
MDA Mean (SD) 0.8 (0.28) 0.91 (0.44) 0.74 (0.15)
Median (IQR) 0.75 (0.53) 0.97 (0.72) 0.70 (0.25)
γH2Ax %
positive nuclei
Mean (SD) 3.6 (6.8) 20.6 (22.6) 14.1 (17.5)
Median (IQR) 0 (3.9) 14.7 (31.5) 3.2 (26.0)
p53 % positive
nuclei
Mean (SD) 15.4 (6.7) 20.9 (7.2) 12.2 (7.7)
Median (IQR) 17.2 (14.7) 19.6 (13.9) 10.1 (12.7)
8-OHdG = 8-hydroxy-2′-deoxoguanosine; CNL = controls non-lesional;
IQR = interquartile range; MDA = malondialdehyde; SD = standard
deviation; WML = white matter lesions.
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matter, with bands on Western blotting of 17 kDa and 480 kDa,
respectively (Figure 4). The percentage of γH2Ax-positive nuclei
was assessed and quantified (Table 2). The γH2Ax and 8-OHdG
counts showed a moderate correlation (Spearman = 0.36). The
γH2Ax counts showed a similar effect with lesion type to the
8-OHdG, although the effects were slightly attenuated (P = 0.03)
with CL being higher than CNL (P = 0.03), although the other post
hoc adjusted comparisons were not significant (all P > 0.05).
(Figure 3C). To determine whether nuclear oxidative DNA damage
may have a detrimental effect on white matter cells, we examined
the expression of markers for senescence. SA-β-gal activity was
demonstrated histochemically in white matter, suggesting induc-
tion of senescence mechanisms (Figure 5A), but was not group-
specific. Double-labeling studies demonstrated that SA-β-gal
activity was present in astrocytes (GFAP+) and oligodendrocytes
(OSP+), but was not observed in CD68-positive microglia
(Figure 5B–D).
To further assess the possibility of senescence induction, we
examined expression of the cell cycle checkpoint protein p16. This
was expressed in astroglial cells, where it co-localized with SA-β-
gal activity (Figure 5E). Quantification of SA-β-gal and p16 did
not reveal differences between groups. Given the presence of p16
in the cytoplasm of astrocytes, we sought to determine whether
p16 expression was associated with gliosis (irrespective of group).
A weak relationship between p16 + cell count with GFAP area
immunoreactivity was found (rho = 0.29, P = 0.11 Figure 6), but
not in the p16 area immunoreactivity (rho = 0.17, P = 0.40).
We compared the expressions of several mRNA species using a
customized qRT-PCR panel (Supporting Information Figure S1) to
seek further evidence for a pattern increased expression of genes
related to DNA damage/senescence in CL and WML and to iden-
tify additional candidate senescence or DNA damage proteins
(Figure 7A). For ease of comparison we compared changes in each
gene in WML and CL, respectively, to CNL. In particular, expres-
sions of H2AX, TP53, and CDKN1B (encodes p27) were increased
by >1.5-fold in WML compared with CNL, while expression of
the TP53 gene was also increased by >twofold in CL cases. Based
on this RNA expression pattern, and the pivotal role of p53 in
apoptosis and senescence, we selected p53 for further quantifica-
tion. We therefore immunostained for p53 protein (Figure 7B) and
A B C
D E F
G H I
Figure 2. Double-labeling studies for cell specific markers (red fluorescent label). A. GFAP; D. oligodendrocyte-specific protein; G. CD68. 8-hydroxy-
2′-deoxoguanosine detected with 3,3’-diaminobenzidine (DAB) label visualized under light microscopy (B, E, H). Merged images shown in C, F and
I. Arrows identify example double-labeled cells. Scale bar 50 μm.
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quantified expression. Expression of p53 showed significant vari-
ation among groups (P = 0.01. Figure 7C). As for the RNA, the
highest levels of p53 expression were in the CL group, and the
expression pattern was similar to those of the other oxidative
damage markers (see Figure 3). However, for p53 protein expres-
sion, levels were lowest in the lesions that showed lower counts
than the CL group and the control group (P = 0.001, CL and
P = 0.08 CNL).
DISCUSSION
The expression of markers of oxidative damage and of DNA
damage response inWML and in CL suggests that oxidative stress
plays a role in the pathogenesis of WML. The highest levels of
expression were observed in apparently normal white matter from
cases with lesions (CL), indicating that oxidative damage in white
matter in cases with WML is extensive. Oxidative cell damage
has previously been shown in white matter in multiple sclerosis,
using immunohistochemistry to 8-OHdG and lipid peroxidation
markers, and associated with evidence of cellular injury (15). In
that situation, injury correlated with inflammation. Our study now
shows that similar cellular mechanisms may cause glial damage in
the context of age-related “ischemic” white matter pathology.
Although not primarily inflammatory, as in multiple sclerosis,
inflammation is a feature of WML and surrounding apparently
normal white matter, where microglial activation is increased (37)
Figure 3. Box plots showing variation in
8-hydroxy-2′-deoxoguanosine counts (A),
malondialdehyde (MDA) protein by western
blot (B) and γH2Ax counts among the three
groups. D. Example Western blot for MDA
showing expected size band at 64 kDa.
Figure 4. Immunohistochemistry showing
nuclear expression of γH2Ax (A) and DNA
protein kinase (B). Scale bars 50 μm. C and
D. Western blots detecting bands of the
expected sizes.
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and blood–brain barrier changes may have proinflammatory
effects (32). So, inflammatory processes, in addition to effects of
chronic ischemia and aging effects are possible contributors to
oxidative DNA damage in ischemic white matter pathology.
The principal marker selected for this study was 8-OHdG, an
oxidative modification to a base that has been widely used as a
marker of oxidative DNAdamage, including in studies of aging and
Alzheimer’s disease, because of its relative sensitivity resulting
from its low oxidation potential (27, 40). Antibodies to this marker
also label oxidative damage to RNA andmitochondrial DNA, but in
this study, as we were interested in the nuclear DNA damage
response, we have focused on nuclear expression. A limitation of
our quantification is thatwe counted immunopositive cells, but once
a detection threshold is reached, this does not take account of the
extent of DNA base modification within a particular cell, and so
may underestimate the real variability. The pattern of highest levels
of damage in lesional control tissue was also supported by assess-
ment ofMDA, amarker of lipid peroxidation, and γH2Ax, a histone
that is phosphorylated in response to DNA double strand breaks,
markers that we have previously used in studies in CFAS (36).
Expression ofMDAand γH2Ax did not reach significance, presum-
ably related to the extent of intrinsic inter-case variation in human
autopsymaterial and limited sample size.However, they showed the
same pattern of variation among groups as the 8-OHdG, while the
good correlation between 8-OHdG and γH2Ax is consistent with
the induction of a DNA damage response in cells with the oxidative
nucleic acid modification.
Higher levels of oxidative/DNA damage were seen in lesional
controls than in the WML themselves. This may suggest that
pathogenic mechanisms are more active in surrounding apparently
normal white matter than in the established lesions. We have pre-
viously shown microglial activation in lesional control white
matter (37), while gene microarray studies show similar pathway
alterations in lesional control white matter and WML (35). We
therefore suggested a “field-effect,” wherebyWML are association
Figure 5. Expression of senescence markers. A. β-gal expression in cells (arrows). B. β-gal (blue) colocalized with oligodendrocyte-specific protein
(brown) indicating expression in oligodendrocytes (arrows). C. Colocalization of β-gal with the astrocyte marker GFAP (arrows). D. β-gal and CD68
double-staining. β-gal reactivity (arrows) does not colocalize with CD68 (open arrows). E. Colocalization of β-gal with p16 (arrow).
Figure 6. Scatterplot showing the association between p16 cell count
and area immunoreactivity for GFAP.
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with more widespread white matter dysfunction. The present
results suggest that oxidative stress and DNA damage may con-
tribute to this environment, causing glial cell dysfunction in this
non-lesional white matter. The relationship of this to lesion patho-
genesis, particularly whether these changes provide an environ-
ment in which MRI-recognizable lesions develop or whether it is
secondary to the lesions, and its contribution to cognitive dysfunc-
tion remain to be determined.
Double-labeling studies demonstrated DNA damage in glia and
endothelial cells. Expression in individual cell types is an impor-
tant question, but our double-labeling was not sufficiently clear to
allow reliable quantitation in these preparation. We therefore did
not attempt to quantify the cell types separately. 8-OHdG expres-
sion was uncommon in GFAP-positive astrocytes, paralleling find-
ings in multiple sclerosis where most 8-OHdG cells were
oligodendrocytes (15).
DNA damage can cause cell dysfunction or loss via apoptosis,
and a persistent DNA damage response can induce senescence
(44). The expression array study further supported increased
expression of genes associated with DNA damage, particularly
p53, which can mediate apoptosis, cell cycle processes and senes-
cence following DNA damage (16).
SA-β-gal activity has been considered to be a marker of senes-
cence in tissues. Senescence as a process was defined initially
as a cell culture phenotype involving cessation of replication
(replicative senescence), but it is becoming recognized in human
tissue and senescent cells have recently been identified in neurons
in brain (19, 42) and in cortical astrocytes (36). The expression
of SA-β-gal now identified in white matter astrocytes and
oligodendrocytes thus suggests induction of senescence mecha-
nisms in glial cells. This was supported in astrocytes by the expres-
sion of the cell cycle checkpoint protein p16, which is involved in
Figure 7. A. Variation in gene expression between control non-lesional, control lesional (CL) and deep subcortical (here labeled DSCL) from RTqPCR
array, Error bars represent standard deviations B. Expression of p53 (scale bar 50 μm). C. Boxplot showing variation in percentage of nuclei positive
for p53 among the three groups, with higher values in the CL group.
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some senescence induction pathways (42), and which appeared to
co-localize with SA-β-gal in these cells. Astrocytes have been
suggested to show features of senescence and a senescence-
associated secretory phenotype in association with GFAP
up-regulation in brain aging (33). The co-expression of p16 and
SA-β-gal in our study, and the suggestion of an association
between p16 and gliosis, raises the question of whether p16 is
involved in induction of gliosis and senescence in these cells. It
should be noted, although, that cells that double-stained for
8-OHdG and GFAP were uncommon, so it is possible that induc-
tion of senescence in astrocytes in white matter may involve
mechanisms other than 8-OHdG-associated DNA damage.
Quantification of SA-β-gal expression was difficult in these
tissues, as has been previously noted in tissue sections (24), and we
did not demonstrate clear differences among our groups. There-
fore, at this stage, we cannot be certain of its relation to lesions, as
compared with other potential drivers, such as age. However,
senescent cells are not only dysfunctional, but may also contribute
to tissue damage through the senescence-associated secretory phe-
notype, which can have various effects within the tissue including
pro-inflammatory effects (6, 22). It therefore has potentially
important implications for age-related WMLs through a variety of
possible mechanisms, including loss of glial support for myelin
and axons, and for the induction of pro-inflammatory environment
and microglia.
Human autopsy-based studies necessarily have a number of
limitations, related to inherent inter-individual variability and peri/
post-mortem factors. In addition the cohort size was relatively
small. This may have masked differences between the groups for
some of the markers. While a strength of the CFAS cohort is its
population base, it should also be noted that the cases here were
pre-selected to represent WML, CL and CNL, so this study is not
population representative, but is in essence a case control study
nested within the CFAS population neuropathology cohort. We
also do not yet have detailed data on axonal pathology in white
matter, so that we are not able in this study to take account of
interactions with axonal damage that might be arising secondary to
cortical pathology, such as Alzheimer’s, which can produce white
matter damage (4).
In conclusion, oxidative DNA damage and a DNA damage
response are features of the pathogenesis of WML and more so of
the apparently normal white matter in cases with lesions, contrib-
uting to the concept that WML are associated with a field-effect of
white matter abnormality. Activation of downstream processes,
such as senescence, are candidate mechanisms for altered glial
function in white matter. Age-relatedWML pathogenesis therefore
involves active cellular processes, especially in surrounding white
matter, which need to be understood as they may be molecular
targets for improving white matter function and repair, and for
preventing new lesions.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Figure S1. Genes included in the customized RT-qPCR array.
Figure S2. Counting of 8-OHdG-positive cells.A.Grid overlay to
facilitate counting. B. Bland–Altmann plot showing variation in
counts between two observers; the red line represents the mean
difference in counts between observers while blue lines are the
limits of agreement (mean difference ± 2 SD of mean difference).
C. Correlation between two observers showing very good agree-
ment for ranking of cases according to 8-OHdG counts.
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